BRUSSELS, Jan 8 (Reuters) - The head of the European
Commission Ursula von der Leyen said on Friday the EU had
reached a deal with Pfizer and BioNTech for
300 million additional doses of their COVID-19 vaccines,
doubling the amount of doses from these producers.
(Reporting by Francesco Guarascio @fraguarascio)
Glaxosmithkline (GSK)
Astrazeneca (AZN)28 Jun 2024 19:43
IN BRIEF: GSK reaches settlement over Zantac case in Illinois
GSK PLC - London based pharmaceuticals company - Reaches confidential settlement with Martin Gross resolving the case he filed in Illinois state court...
